SPONSOR
The First Affiliated Hospital of Xiamen University
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Multiple MyelomaRelapsed/RefractorySSTR2FAPPositron-Emission TomographyNasopharyngeal Carcinoma (NPC)PET / CTDiffuse Large B-cell LymphomaRelapsed and RefractoryPositron-Emission Tomography(PET)
The First Affiliated Hospital of Xiamen University is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Multiple Myeloma, Relapsed/Refractory, SSTR2, FAP.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The First Affiliated Hospital of Xiamen University
How many clinical trials has The First Affiliated Hospital of Xiamen University sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by The First Affiliated Hospital of Xiamen University, of which 5 are actively recruiting participants. These trials cover conditions including Multiple Myeloma, Relapsed/Refractory, SSTR2. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The First Affiliated Hospital of Xiamen University research focus on?
The First Affiliated Hospital of Xiamen University clinical trials span Multiple Myeloma, Relapsed/Refractory, SSTR2, FAP, Positron-Emission Tomography, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The First Affiliated Hospital of Xiamen University clinical trial?
To participate in a The First Affiliated Hospital of Xiamen University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The First Affiliated Hospital of Xiamen University trials with current recruitment status updated daily.
Clinical Trials by The First Affiliated Hospital of Xiamen University
NCT06581640 Phase 2
Recruiting
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
NCT05873777
Recruiting
68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG
SSTR2
NCT07137052
Recruiting
Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma (NPC)
NCT06651853 Phase 2
Recruiting
Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL
Diffuse Large B-cell Lymphoma
NCT06696326
Recruiting
A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer
Positron-Emission Tomography(PET)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology